Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunodeficiency disorders.

Max D Cooper, Lewis L Lanier, Mary Ellen Conley

    Hematology. American Society of Hematology. Education Program
    |November 25, 2003
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients With Inborn Errors of Immunity From the Primary Immune Deficiency Treatment Consortium (PIDTC).

    The journal of allergy and clinical immunology. In practice·2026
    Same author

    2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS).

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
    Same author

    Assessment of TREC-Based NBS SCID Reporting Practices for Harmonization of Results and Interpretation: A Global Survey.

    The journal of allergy and clinical immunology. In practice·2026
    Same author

    Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC study.

    Journal of human immunity·2026
    Same author

    Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriers.

    Clinical immunology (Orlando, Fla.)·2025
    Same author

    Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.

    Blood advances·2025
    Same journal

    Nze C, Flowers CR. Barriers to accessing cellular therapy for patients receiving care in community practices. Hematology Am Soc Hematol Educ Program. 2023;2023(1):382-385.

    Hematology. American Society of Hematology. Education Program·2025
    Same journal

    CAR T-cell therapy and bispecific antibodies in the management of multiple myeloma.

    Hematology. American Society of Hematology. Education Program·2025
    Same journal

    Emerging immunotherapy advances for non-Hodgkin lymphomas: engaging T cells in the fight.

    Hematology. American Society of Hematology. Education Program·2025
    Same journal

    Anticoagulants in hematologic malignancies: what is the data?

    Hematology. American Society of Hematology. Education Program·2025
    Same journal

    Diagnosis and management of cold agglutinin disease.

    Hematology. American Society of Hematology. Education Program·2025
    Same journal

    What to know about rare B-cell malignancies in 2025.

    Hematology. American Society of Hematology. Education Program·2025
    See all related articles

    Hematological complications are common in immunodeficiency disorders, affecting T cells, B cells, and innate immunity. This session updates the diagnosis and treatment of antibody deficiencies and severe combined immunodeficiencies (SCID).

    Area of Science:

    • Immunology
    • Hematology
    • Genetics

    Background:

    • Hematological complications like anemia and thrombocytopenia are frequent in primary and secondary immunodeficiency disorders.
    • Immunodeficiency diseases involve defects in T and B cells, but innate immune mechanisms also play a crucial role in host defense.
    • Understanding immunoreceptors on various immune cells is vital for comprehending host defense mechanisms.

    Purpose of the Study:

    • To provide an update on the diagnosis and treatment of immunodeficiency diseases.
    • To review the role of immunoreceptors in host defense.
    • To discuss antibody deficiency disorders and severe combined immunodeficiencies (SCID).

    Main Methods:

    • Review of current literature on immunoreceptors and their functions in host defense.

    Related Experiment Videos

  • Definition and categorization of antibody deficiency disorders, including B-cell defects.
  • Discussion of diagnostic and therapeutic approaches for SCID, including genetic basis and treatment modalities.

    • Main Results:

    • Immunoreceptors on NK, dendritic, T, B, and phagocytic cells are critical for host defense.
    • Antibody deficiency disorders represent the most common primary immunodeficiencies, with diverse B-cell defects.
    • SCID has a genetic basis, and treatments like gene therapy and bone marrow transplantation have benefits and risks.

    Conclusions:

    • A comprehensive understanding of both adaptive and innate immunity is essential for managing immunodeficiency disorders.
    • Accurate diagnosis and timely treatment of antibody deficiencies and SCID are crucial for patient outcomes.
    • Advances in understanding immunoreceptors and treatment modalities are improving the management of complex immunodeficiencies.